Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells

Journal of Nutrition, Health and Aging

Volumn 18, Issue 2, 2014, Pages 184-190

  Yang, Y H ^a,b   Hsieh, T J ^b   Tsai, M L ^a   Chen, C H ^c   Lin, H T ^a   Wu, Shyh Jong ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Alzheimer's disease; Heme oxygenase 1; Neuron degeneration; Oxidative stress; Reactive oxygen species; SH SY5Y

Indexed keywords

ANTIOXIDANT; DOCOSAHEXAENOIC ACID; FOLIC ACID; GINKGO BILOBA EXTRACT; HEME OXYGENASE 1; HERBACEOUS AGENT; HU YI NENG; HYDROGEN PEROXIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLSERINE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; DIACETYLDICHLOROFLUORESCEIN; FLUORESCEIN DERIVATIVE; HMOX1 PROTEIN, HUMAN; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

ANTIOXIDANT ACTIVITY; ARTICLE; BARK; CELL LEVEL; CELL LOSS; CELL STRAIN SY5Y; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PINE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; APOPTOSIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; TAIWAN; TUMOR CELL LINE;

ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DIETARY SUPPLEMENTS; FLUORESCEINS; HEME OXYGENASE-1; HUMANS; HYDROGEN PEROXIDE; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PINUS; PLANT BARK; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; TAIWAN;

EID: 84898935413     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-013-0382-3     Document Type: Article

References (40)

1. Brunden KR, Trojanowski JQ, Lee VM Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 2009;8:783-793.
2. Ittner LM, Gotz JAmyloid-beta and tau - a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 2011;12:65-72.
3. Pangalos MN, Schechter LE, Hurko O.Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov 2007;6:521-532. (Pubitemid 47019441)
4. Becker RE, Greig NH.Alzheimer's disease drug development in 2008 and beyond: problems and opportunities. Curr Alzheimer Res 2008;5:346-357.
5. Kishi T, Ikeda M, Kitajima T et al.Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population. Ann N Y Acad Sci 2008;1139:70-82.
6. Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E.Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 2003;24:1079-1085. (Pubitemid 37487885)
7. Peretz I, Gosselin N, Belin P, Zatorre RJ, Plailly J, Tillmann B.Music lexical networks: the cortical organization of music recognition. Ann N Y Acad Sci 2009;1169:256-265.
8. Fiers W, Beyaert R, Declercq W, Vandenabeele P.More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 1999;18:7719-7730. (Pubitemid 30052757)
9. Yan LJ, Levine RL, Sohal RS.Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A 1997;94:11168-11172. (Pubitemid 27450969)
10. Suh JH, Heath SH, Hagen TM.Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic Biol Med 2003;35:1064-1072. (Pubitemid 37315699)
11. Sastre J, Pallardo FV, Pla R, Pellin A, Juan G, O'Connor JE et al.Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology 1996;24:1199-1205. (Pubitemid 26365926)
12. Shigenaga MK, Hagen TM, Ames BN.Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A 1994;91:10771-10778. (Pubitemid 24349567)
13. Pocernich CB, Lange ML, Sultana R, Butterfield DA.Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Curr Alzheimer Res 2011;8:452-469.
14. Covas MI, Gambert P, Fito M, de la Torre R.Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. Atherosclerosis 2010;208:297-304.
15. Guo W, Kong E, Meydani MDietary polyphenols, inflammation, and cancer. Nutr Cancer 2009;61:807-810.
16. Sesti F, Liu S, Cai SQ.Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration? Trends Cell Biol 2010;20:45-51.
17. Cai SQ, Sesti F.Oxidation of a potassium channel causes progressive sensory function loss during aging. Nat Neurosci 2009;12:611-617.
18. Lee HP, Zhu X, Casadesus G, Castellani RJ, Nunomura A, Smith MA et al.Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neurother 2010;10:1201-1208.
19. Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J et al.Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Deliv Rev 2008;60:1463-1470.
20. Kelley BJ, Knopman DS.Alternative medicine and Alzheimer disease. Neurologist 2008;14:299-306.
21. Halliwell B.Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-1623.
22. Harman D.Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 2006;1067:10-21. (Pubitemid 43806304)
23. Ames BN.Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci U S A 2006;103:17589-17594.
24. Corbetta M, Patel G, Shulman GL.The reorienting system of the human brain: from environment to theory of mind. Neuron 2008;58:306-324. (Pubitemid 351615192)
25. Devore EE, Kang JH, Stampfer MJ, Grodstein F.Total antioxidant capacity of diet in relation to cognitive function and decline. Am J Clin Nutr 2010;92:1157-1164.
26. Kamphuis PJ, Scheltens P.Can nutrients prevent or delay onset of Alzheimer's disease? J Alzheimers Dis 2010;20:765-775.
27. Lindsay DG, Astley SB.European research on the functional effects of dietary antioxidants - EUROFEDA. Mol Aspects Med 2002;23:1-38. (Pubitemid 34669880)
28. Gray SL, Anderson ML, Crane PK, Breitner JC, McCormick W, Bowen JD et al.Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. J Am Geriatr Soc 2008;56:291-295. (Pubitemid 351160681)
29. Yaffe K.Antioxidants and prevention of cognitive decline: does duration of use matter? Arch Intern Med 2007;167:2167-2168. (Pubitemid 350106734)
30. Le WD, Xie WJ, Appel SH.Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J Neurosci Res 1999;56:652-658. (Pubitemid 29246847)
31. Hu CM, Chen YH, Chiang MT, Chau LY.Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 2004;110:309-316.
32. Otterbein LE, Soares MP, Yamashita K, Bach FH.Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-455. (Pubitemid 36928103)
33. Cuadrado A, Rojo AI.Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections. Curr Pharm Des 2008;14:429-442. (Pubitemid 351516848)
34. Chien WE, Lee TR, Hung SY, Kang KH, Lee MJ, Fu WM.Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1. J Neurochem 2011;117:643-653.
35. Wruck CJ, Gotz ME, Herdegen T, Varoga D, Brandenburg LO, Pufe T.Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol 2008;73:1785-1795. (Pubitemid 351724366)
36. Furukawa Y, Urano T, Minamimura M, Nakajima M, Okuyama S, Furukawa S.4-Methylcatechol-induced heme oxygenase-1 exerts a protective effect against oxidative stress in cultured neural stem/progenitor cells via PI3 kinase/Akt pathway. Biomed Res 2010;31:45-52.
37. Quesada A, Ogi J, Schultz J, Handforth A.C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase C/Nrf2 pathway. J Neurosci Res 2011;89:394-405.
38. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I et al.Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008;14:458-470.
39. Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H.Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells. Cancer Chemother Pharmacol 2011;67:1129-1136.
40. Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ.Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J Am Diet Assoc 2007;107:1322-1332. (Pubitemid 47101762)